Bayer Eyes $7.25 Billion Glyphosate Deal as Shares Drop Over 8%
Bayer revealed a proposed $7.25 billion class settlement intended to resolve the bulk of U.S. glyphosate claims and announced additional agreements that raise total legal provisions to 11.8 billion euros. The plan, which would spread payments over as long as 21 years with heavier payments in 2026-2031, sent the stock down more than 8%. The deal rem…